Thirona, a Dutch company that specializes in advanced analysis of thoracic CT images with artificial intelligence (AI), has secured €7.5 million in funding to advance precision medicine and enhance patient care for lung diseases.
The funding includes a €5 million investment from two venture capital firms, HERAN Partners and the Borski Fund, both of which focus on supporting healthcare and technology-based sectors in Europe. The company also received a €2.5 million grant from the European Innovation Council (EIC), a public body that supports innovation and entrepreneurship across the European Union.
Thirona was founded in 2014 by Eva van Rikxoort, a researcher and entrepreneur with expertise in lung image analysis. The company provides high-precision AI-based services for MedTech, pharmaceutical, and CRO companies, as well as research institutions and medical companies. Thirona’s mission is to utilize the latest domain knowledge and AI technology to create a positive impact by making personalized treatments for lung diseases accessible to everyone.